602 related articles for article (PubMed ID: 19661359)
1. Clinicopathological and immunohistochemical characteristics of esophageal carcinosarcoma.
Sano A; Sakurai S; Kato H; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Sakamoto K; Sano T; Hosoya Y; Enomoto T; Kanda T; Ajioka Y; Oyama T; Kuwano H
Anticancer Res; 2009 Aug; 29(8):3375-80. PubMed ID: 19661359
[TBL] [Abstract][Full Text] [Related]
2. Esophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation.
Amatya VJ; Takeshima Y; Kaneko M; Inai K
Pathol Int; 2004 Oct; 54(10):803-9. PubMed ID: 15482572
[TBL] [Abstract][Full Text] [Related]
3. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.
Sano A; Kato H; Sakurai S; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Nakajima T; Kuwano H
Ann Surg Oncol; 2009 Feb; 16(2):506-14. PubMed ID: 19050962
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological studies of esophageal carcinosarcoma: analyses of its morphological characteristics using endoscopic, histological, and immunohistochemical procedures.
Chino O; Kijima H; Shimada H; Nishi T; Tanaka H; Oshiba G; Kise Y; Kenmochi T; Himeno H; Tsuchida T; Kawai K; Tanaka M; Machimura T; Tajima T; Makuuchi H
Endoscopy; 2000 Sep; 32(9):706-11. PubMed ID: 10989995
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological analysis of esophageal carcinosarcoma:a report of 22 cases].
Yu Z; Cheng BC; Chang S; Huang J; Mao ZF; Kang GJ; Lin HQ; Xiao YG
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 May; 11(3):235-7. PubMed ID: 18478466
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase II alpha expression in esophageal squamous cell carcinoma.
Ohashi Y; Sasano H; Yamaki H; Shizawa S; Kikuchi A; Shineha R; Akaishi T; Satomi S; Nagura H
Anticancer Res; 1999; 19(3A):1873-80. PubMed ID: 10470130
[TBL] [Abstract][Full Text] [Related]
7. Carcinosarcoma of the esophagus: a twenty-case study.
Iyomasa S; Kato H; Tachimori Y; Watanabe H; Yamaguchi H; Itabashi M
Jpn J Clin Oncol; 1990 Mar; 20(1):99-106. PubMed ID: 2319703
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of the histogenesis of esophageal carcinosarcoma.
Wang ZY; Itabashi M; Hirota T; Watanabe H; Kato H
Jpn J Clin Oncol; 1992 Dec; 22(6):377-86. PubMed ID: 1283991
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma.
Lam KY; Law SY; So MK; Fok M; Ma LT; Wong J
Cancer; 1996 Jan; 77(1):7-13. PubMed ID: 8630942
[TBL] [Abstract][Full Text] [Related]
10. Carcinosarcoma of the esophagus: three cases with immunohistological examination.
Imada T; Yoneyama K; Suzuki Y; Nagano A; Hasuo K; Takahashi M; Rino Y; Ozawa Y; Amano T; Kondo J
Hepatogastroenterology; 1998; 45(24):2193-6. PubMed ID: 9951893
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients.
Iwasa Y; Haga H; Konishi I; Kobashi Y; Higuchi K; Katsuyama E; Minamiguchi S; Yamabe H
Cancer; 1998 Feb; 82(3):512-9. PubMed ID: 9452269
[TBL] [Abstract][Full Text] [Related]
12. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
Koide N; Nishio A; Sato T; Sugiyama A; Miyagawa S
Am J Gastroenterol; 2004 Sep; 99(9):1667-74. PubMed ID: 15330899
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma.
Kuo KT; Wang HW; Chou TY; Hsu WH; Hsu HS; Lin CH; Wang LS
Ann Surg Oncol; 2009 Feb; 16(2):352-60. PubMed ID: 19050969
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous carcinosarcoma: adnexal vs. epidermal types define high- and low-risk tumors. Results of a meta-analysis.
Tran TA; Muller S; Chaudahri PJ; Carlson JA
J Cutan Pathol; 2005 Jan; 32(1):2-11. PubMed ID: 15660649
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic value of MG7-Ag in patients with surgically resectable esophageal squamous cell carcinoma.
Zhao Y; Jiang Y; Wang R; Zheng X; Wang X; Jin B; Lu Y; Qiao T; Hong L; Fan D
Ann Surg Oncol; 2007 Sep; 14(9):2621-7. PubMed ID: 17570016
[TBL] [Abstract][Full Text] [Related]
16. Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
Kato H; Takita J; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(5):2635-9. PubMed ID: 12529975
[TBL] [Abstract][Full Text] [Related]
17. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients.
Hoshino I; Matsubara H; Akutsu Y; Nishimori T; Yoneyama Y; Murakami K; Sakata H; Matsushita K; Ochiai T
Oncol Rep; 2007 Oct; 18(4):867-71. PubMed ID: 17786348
[TBL] [Abstract][Full Text] [Related]
19. A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma.
Kato H; Miyazaki T; Fukai Y; Nakajima M; Sohda M; Takita J; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Asao T; Kuwano H
J Surg Oncol; 2003 Sep; 84(1):24-30. PubMed ID: 12949987
[TBL] [Abstract][Full Text] [Related]
20. Strong impact of micrometastatic tumor cell load in patients with esophageal carcinoma.
Koenig AM; Prenzel KL; Bogoevski D; Yekebas EF; Bubenheim M; Faithova L; Vashist YK; Gawad KA; Baldus SE; Pantel K; Schneider PM; Hölscher AH; Izbicki JR
Ann Surg Oncol; 2009 Feb; 16(2):454-62. PubMed ID: 19015923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]